September 17, 2019
Perspectum Announces FDA Grant Award for LiverMultiScan to Help NASH Patients
DALLAS–(BUSINESS WIRE)–The Food and Drug Administration (FDA) has awarded Perspectum Inc $250,000 to qualify its proprietary biomarkers for NASH in…